These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 6819173

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes.
    Jaspan JB, Towle VL, Maselli R, Herold K.
    Metabolism; 1986 Apr; 35(4 Suppl 1):83-92. PubMed ID: 3083212
    [Abstract] [Full Text] [Related]

  • 24. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.
    Int J Exp Diabetes Res; 2002 Apr; 3(1):21-36. PubMed ID: 11900277
    [Abstract] [Full Text] [Related]

  • 25. Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.
    Jaspan JB, Herold K, Bartkus C.
    Am J Med; 1985 Nov 15; 79(5A):24-37. PubMed ID: 3000176
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Can aldose reductase inhibition ameliorate diabetic neuropathy?
    González ER.
    JAMA; 1981 Sep 11; 246(11):1169-70. PubMed ID: 6790734
    [No Abstract] [Full Text] [Related]

  • 28. Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2',5'-dioxospiro-[chroman-4,4'-imidazolidine]-2-carbox amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats.
    Kato N, Mizuno K, Matsubara A, Nakano K, Kurono M, Yagihashi S.
    J Diabetes Complications; 1994 Sep 11; 8(1):27-32. PubMed ID: 8167384
    [Abstract] [Full Text] [Related]

  • 29. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
    Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AA, Greene DA.
    Diabetologia; 1993 Jul 11; 36(7):608-14. PubMed ID: 8359577
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes.
    Lowitt S, Malone JI, Salem AF, Korthals J, Benford S.
    Metabolism; 1995 May 11; 44(5):677-80. PubMed ID: 7752919
    [Abstract] [Full Text] [Related]

  • 33. Aldose reductase inhibitors and late complications of diabetes.
    Benfield P.
    Drugs; 1986 May 11; 32 Suppl 2():43-55. PubMed ID: 3098544
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
    Greene DA, Mackway AM.
    Diabetes; 1986 Oct 11; 35(10):1106-8. PubMed ID: 3019804
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Aldose reductase inhibition in diabetes.
    Clarke BF, Young RJ, Martyn CN, Ewing DJ.
    Diabet Med; 1984 Jul 11; 1(2):88-90. PubMed ID: 6242793
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function.
    Jaspan J, Maselli R, Herold K, Bartkus C.
    Lancet; 1983 Oct 01; 2(8353):758-62. PubMed ID: 6137601
    [Abstract] [Full Text] [Related]

  • 40. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
    Obrosova IG, Van Huysen C, Fathallah L, Cao XC, Greene DA, Stevens MJ.
    FASEB J; 2002 Jan 01; 16(1):123-5. PubMed ID: 11709499
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.